相关实验视频

Updated: Jul 17, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

针对非前列腺癌的PSMA向治疗

Jarey H Wang¹, Ana P Kiess¹

¹Department of Radiation Oncology and Molecular Radiation Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.

Frontiers in oncology

|August 30, 2023

概括

前列腺特异性膜抗原 (PSMA) 向的放射性连接体疗法 (RLT) 在前列腺癌之外显示出希望. 研究正在探索其在唾液腺癌,细胞癌,质瘤和肉瘤中的应用,需要进一步研究才能获得最佳应用.

科学领域:

在瘤学瘤学.
核医学是一种核医学.
放射性药物疗法是一种放射性药物疗法.

背景情况:

放射性干疗法 (RLT) 对诸如转移性割抗性前列腺癌 (m-CRPC) 等侵袭性癌症至关重要.
前列腺特异性膜抗原 (PSMA) 向的RLT现在已获得FDA对m-CRPC.的批准.
在非前列腺瘤中的PSMA表达表明潜在的治疗应用.

研究的目的:

审查目前非前列腺癌中PSMA向RLT的临床进展.
突出早期发现和各种恶性瘤的潜在益处.
确定PSMA RLT未来研究领域的新指示.

主要方法:

临床研究和涉及非前列腺癌中PSMA RLT的病例系列的文献综述.
分析报告的疗效,安全性和患者选择标准.
确定促进PSMA RLT在新癌症类型中的关键研究问题.

主要成果:

来自小队列的早期数据表明,PSMA RLT在唾液腺癌,细胞癌,高度质瘤和软组织肉瘤中具有前景.
在瘤围膜和新血管系统中PSMA的表达是向的关键因素.
患者的选择和了解PSMA表达水平对于治疗成功至关重要.

结论:

针对PSMA的RLT是一种有前途的治疗策略,用于选择非前列腺癌.
进一步的研究对于优化剂量测量,利用PSMA PET/CT成像作为生物标志物以及建立安全性和有效性概况至关重要.
确定哪些特定患者群体将从PSMA RLT中获益最多,对于临床实施至关重要.

关键词:

在PSMA上,PSMA可以在PSMA上进行交易.质母细胞瘤是什么卢-177的使用情况其他非前列腺癌的癌症放射性干疗法 (RLT) 是一种疗法.细胞癌瘤是细胞癌.唾液腺癌唾液腺癌是一种软组织肉瘤软组织肉瘤

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...